
Opinion|Videos|July 4, 2024
A Conversation on Combination Therapy, Safety Profiles, and Targeted IL-17 Systemic Treatments
The experts discuss combination therapy approaches, safety considerations, and targeted interleukin-17 systemic treatments for plaque psoriasis.
Advertisement
Episodes in this series

Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
2
French Early Access Data on Dupilumab in Pediatric Atopic Dermatitis
3
New Clinical Insights Into Hair Loss Disorders and the Vitamin D Receptor
4
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
5


















